Emerging evidence suggests that newly diagnosed T2DM patients show significantly upregulated protein expression of NLRP3, ASC, caspase-1, IL-1β and IL-18 among monocyte-derived macrophages [11]. This evidence concerns the gene NLRP3 and type 2 diabetes mellitus.